Kynam Capital Management, LP Catalyst Biosciences, Inc. Transaction History

Kynam Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.33 - $0.65 $56 - $111	172 Added 0.19%	90,058 $43,000
Q1 2023 May 15, 2023	SELL	$0.19 - $0.64 $113 - $382	-598 Reduced 0.66%	89,886 $18,000
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.57 $145 - $168	296 Added 0.33%	90,484 $47,000
Q3 2022 Nov 14, 2022	SELL	$0.49 - $1.95 $1,590 - $6,329	-3,246 Reduced 3.47%	90,188 $45,000
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $4,555 - $22,525	-12,655 Reduced 11.93%	93,434 $166,000
Q1 2022 May 13, 2022	SELL	$0.51 - $1.0 $2,500 - $4,902	-4,902 Reduced 4.42%	106,089 $70,000
Q4 2021 Feb 14, 2022	BUY	$0.91 - $4.16 $101,001 - $461,722	110,991 New	110,991 $101,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.